CD4 and central nervous system cancer: Comparable to ALE, IDH-wildtype glioma patients were characterized by a pronounced PB and CSF adaptive immune response with an increase in activated CD4+ and CD8+ Tc in PB and CSF, and Bc in CSF (Fig. 1B, F, H, P, R, U).